![]() ![]() Toxoplasma gondii must live inside the cells of its host and secretes many proteins to counter the host's immune defences and to facilitate their own invasion and colonisation of the host cells. The team managed to 'tame' the parasite Toxoplasma gondii - a single-celled opportunistic protozoan capable of infecting a broad range of warm-blooded animals and has been reported in nearly one-third of the world's human population. Scientists leading the study believe that this finding could have broader therapeutic implications for many types of cancers. In this new study, scientists revealed that a parasite found commonly across the globe, is able to sensitise cold tumours - tumours that are not likely to trigger a strong immune response by the body - to immune checkpoint blockade therapy. Improving the effectiveness of treatments against certain types of tumours is vital in order to beat certain cancers, stop tumour progression, and prolong the lives of patients. The research was carried out by experts from the University of Nottingham, Ningbo University and Shanxi Agricultural University in China. The findings of the study were published in the 'Journal for ImmunoTherapy Cancer'. A new study has found that a deadly parasite, known to cause ill health in pregnant women and immunocompromised patients, could potentially be used to treat various types of tumours. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |